Back

CVD prevention and event reduction.

27 August 2017 (12:50 - 13:10)
Organised by:
Congress Presentation Part of: Proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors: the next chapter in cardiovascular disease prevention Atherosclerosis Open Access ESC Congress 2017

About the speaker

Photo
Professor Marc Sabatine

Brigham and Women's Hospital, Harvard Medical School, Boston (United States of America)

4 More presentations in this session

Presentation thumbnail
Introduction - PCSK9 inhibitors: the next chapter in CVD prevention.
Video
Presentation thumbnail
Future perspectives in lipid lowering and CVD prevention.
Professor P. Sever (London, GB)
Presentation thumbnail
Panel discussion - PCSK9 inhibitors: the next chapter in CVD prevention.
Professor J. Chapman (Paris, FR)
Presentation thumbnail
Close - PCSK9 inhibitors: the next chapter in CVD prevention.
Professor J. Chapman (Paris, FR)

Access the full session

Session thumbnail
Proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors: the next chapter in cardiovascular disease prevention

The Event

Event poster

ESC Congress 2017

27 August 2017 12:50 CET

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources